Biologics in Canada. : H82-50/1-2020E-PDF ; H82-50/2-2020E-PDF
"This analysis examines the market dynamics of biologics in Canada and compares Canadian and international trends in sales, pricing, and biosimilar uptake. Part 2 uses recent Canadian and international trends to expose the current and future cost savings that could be realized through increasing the uptake and/or lowering the prices of biosimilars in Canada"--Introduction, page 5.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.885926&sl=1
| Ministère/Organisme | Canada. Patented Medicine Prices Review Board, issuing body. |
|---|---|
| Titre | Biologics in Canada. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique |
|
| Note(s) | "May 2020." Cover title. Issued also in HTML format. "Chartbook National Prescription Drug Utilization Information System (NPDUIS)"--Cover. Issued also in French under title: Les médicaments biologiques au Canada. Includes bibliographical references (page 31). Part 1: Market trends, 2018 -- Part 2: Biosimilar savings, 2018. |
| Information sur la publication | Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020. ©2020 |
| Description | 1 online resource (2 volumes) : graphs |
| ISBN | 9780660345949 9780660345956 |
| Numéro de catalogue |
|
| Descripteurs | Biologicals -- Canada. Biologicals -- Prices -- Canada. Pharmaceutical industry -- Canada. |